Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
FDNA listed in 2020 Insider’s Guide to Precision Medicine, in Clinical OMICS
April 1, 2021
The article from Clinical OMICs: Insider’s Guide 2020, states that FDNA is a key player in advancing precision medicine through its AI-powered tool, Face2Gene. This technology utilizes advanced facial recognition algorithms to analyze facial features and identify genetic disorders accurately. By integrating patient photos and genomic data, Face2Gene delivers precise diagnostic insights swiftly. The tool aids healthcare providers in developing personalized treatment plans, enhancing patient care. FDNA’s innovations in precision medicine demonstrate the transformative potential of AI, offering more accurate diagnoses and tailored healthcare solutions.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…